News | Digital Radiography (DR) | October 04, 2017

Kubtec Announces Expansion of 3-D Tomosynthesis Technology

Technology will now be featured on XPERT 80 Specimen X-ray System to visualize larger specimens

Kubtec Announces Expansion of 3-D Tomosynthesis Technology

October 4, 2017 — Kubtec announced at the annual conference of the American Association of Pathology Assistants (AAPA) that they are expanding their proprietary use of 3-D tomosynthesis by bringing it to the XPERT 80 Specimen X-ray System. Kubtec introduced 3-D imaging for clinical specimens with the Mozart System, the first specimen X-ray system to use 3-D tomosynthesis, according to the company. 
 
This technology has now been scaled up to enable healthcare professionals to visualize larger specimens such as full mastectomies and even the longest of bone specimens — all in 3-D.
 
The digital X-ray company plans to have this technology incorporated into the XPERT 80 System by the end of 2017.

For more information: www.kubtec.com

Related Content

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast. A small mass with micro-calcifications on the right-side breast was detected correctly by AI with an abnormality score of 96%. This case was recalled by 7 out of 14 radiologists (4 breast radiologists and 3 general radiologists) initially (without AI) and all 14 radiologists recalled this case correctly with the assistance of AI.

News | Artificial Intelligence | February 11, 2020
February 11, 2020 — A new study, published in...
aycan completed the install of a second aycan xray-print solution at Inspira Health in New Jersey
News | X-Ray | February 10, 2020
February 10, 2020 — aycan completed the install of a second...
Carestream mobile Xray
News | Digital Radiography (DR) | February 08, 2020
February 8, 2020 — Carestream Health was awarded 37 new paten
Sponsored Content | Videos | Artificial Intelligence | February 06, 2020
ProFound AI is an FDA-cleared artificial intelligence (AI) system for reading 3-D breast tomosynthesis images.
Feature | Breast Imaging | February 03, 2020 | By Barbara Smith
Women in the United States have a 1 in 8 (or about 13 percent) lifetime risk of being diagnosed with breast cancer du
ringing the cancer bell can do more harm than good, says an ASTRO study

Image courtesy of ASTRO

News | Radiation Oncology | January 27, 2020
January 27, 2020 — It's a scene that some cancer patients dream about: they celebrate the end of a course of radiatio
A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast

A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast. (A) Unenhanced fat-saturated T1-weighted MRI shows extreme amount of FGT (ACR d). (B) Moderate BPE is seen on dynamic contrast-enhanced MRI at 90 s. (C) Mean ADC of breast parenchyma of contralateral breast on diffusion-weighted imaging with ADC mapping is 1.5 × 10?3 mm2/s. (D) On 18F-FDG PET/CT, lesion is not 18F-FDG-avid, and BPU of normal breast parenchyma is relatively high, with SUVmax of 3.2. Photo courtesy of K Pinker, et al., Medical University of Vienna, Vienna, Austria

News | PET-MRI | January 27, 2020
January 27, 2020 — Researchers have identified several potentially useful...
Rayence C-Series wireless DR detector

Image courtesy of Rayence

News | Digital Radiography (DR) | January 27, 2020
January 27, 2020 — The expansion of med...
Sponsored Content | Videos | Mammography | January 24, 2020
Imaging Technology News Contributing Editor Greg Freiherr interviewed...